Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2

Status

Completed 5Recruiting 4Active not recruiting 3Not yet recruiting 2Withdrawn 1Unknown 1Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 181Breast 74Gynecologic 66Head & Neck 41Gastrointestinal 35Genitourinary 29Other solid neoplasm 20CNS 13Lymphoid 7Tumor-Agnostic 6Endocrine 4Dermatologic 4Sarcoma 3Other 2Classical hematology 2Other neoplasm 1Other hematologic neoplasm 1

Conditions

Carcinoma, Neuroendocrine 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neuroendocrine Neoplasms 1Multiple Endocrine Neoplasia Type 2a 1Lethal Congenital Contracture Syndrome 2 1Gastrointestinal Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Carcinoma, Non-Small-Cell Lung 1

Interventions

lutetium Lu 177 dotatate 16Magnetic Resonance Spectroscopy 14gallium Ga 68 dotatate 9Specimen Handling 8Everolimus 8pembrolizumab 7cabozantinib 6Cisplatin 6fluorodopa F 18 5Etoposide 5trametinib 4surufatinib 4lanreotide 4dabrafenib 4cemiplimab 4X-Rays 4Temozolomide 4Nivolumab 4Lutetium-177 4Lutetium 4Fluorodeoxyglucose F18 4Carboplatin 4177Lu-octreotide, DOTA(0)-Tyr(3)- 4olaparib 3lenvatinib 3copper dotatate CU-64 3Transurethral Resection of Prostate 3Thyrotropin Alfa 3Surveys and Questionnaires 3Somatostatin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Carboplatin × Endocrine × Clear all
NCT06132113 2026-05-27

DAREONâ„¢-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers

Boehringer Ingelheim

Phase 1 Recruiting
55 enrolled
Endocrine

Neuroendocrine Neoplasms

NCT05142189 2026-04-14

LuCa-MERIT-1

BioNTech SE

Phase 1 Recruiting
320 enrolled
EndocrineThoracic

Diabetes Mellitus, Insulin-Dependent, 12, Lethal Congenital Contracture Syndrome 2, Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Multiple Endocrine Neoplasia Type 2a

NCT04325425 2025-09-30

FOLFIRINEC

Centre Hospitalier Universitaire Dijon

Phase 2 Recruiting
218 enrolled
Endocrine

Carcinoma, Neuroendocrine

NCT04268121 2025-07-23

NEONEC

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Recruiting
78 enrolled
EndocrineGastrointestinal

Gastrointestinal Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡